House mark for a full line of pharmaceutical preparations; pharmaceutical preparations for treating vitamin deficiency; vitamin analogs; pharmaceutical preparations for treating vitamin B12 deficiency; vitamin B12 analogs; pharmaceutical preparations for treating vitamin B9 deficiency; vitamin B9 analogs; pharmaceutical preparations for treating anemia; pharmaceutical preparations for treating vitamin B1 deficiency; vitamin B1 analogs; diuretics; diuretic preparations; pharmaceutical preparations, namely, diuretics; pharmaceutical preparations for enhancing fertility; pharmaceutical antipsychotic preparations; pharmaceutical preparations for the treatment of psychotic disorders; pharmaceutical preparations for increasing GLP-1 levels; GLP-1 receptor agonists for treating diabetes and obesity; methylene blue to treat methemoglobinemia for medical use; dye used in medical, pharmaceutical and veterinary substances; dietetic substances for medical or veterinary purposes, namely, dietary supplements containing methylene blue, in the form of tablets or capsules, or liquid form; antifungal preparations; pharmaceutical preparations, namely, antifungal preparations; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical products for treating autoimmune diseases and disorders; injectable pharmaceutical preparations for treating multiple sclerosis; syringes sold filled with injectable pharmaceutical preparations for treating multiple sclerosis; immunostimulant preparations; pharmaceutical preparations, namely, immunostimulants for increasing white blood cell production; pharmaceutical preparations for treating Paget's disease; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely, osteoporosis, Paget's disease, and other bone-related diseases and disorders; pharmaceutical preparations for treating osteoporosis; pharmaceutical preparations for treating and preventing hypoglycemia; Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for glycemic control; pharmaceutical preparations for treating systemic inflammatory conditions; pharmaceutical preparations, namely, corticosteroids